Natera

Associate Medical Director - Breast

Remote

Not SpecifiedCompensation
Senior (5 to 8 years), Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, BiotechnologyIndustries

Position Overview

  • Location Type: Primarily Remote (with potential for travel)
  • Employment Type: Full-Time
  • Salary: Not Specified

The Associate Medical Director, Breast Oncology is a critical leadership role responsible for advancing clinical development, shaping medical strategy, and engaging external stakeholders in support of Natera’s molecular diagnostics in breast cancer. This individual will drive the adoption of cutting-edge diagnostics into routine clinical practice—initially as an individual contributor, with the potential to build and lead a team as the business scales.

Requirements

  • Education: M.D. and/or Ph.D. required
  • Experience:
    • At least 5 years of post-fellowship clinical experience in breast oncology
    • Minimum 3 years of clinical trial experience in academic, biotech, or pharmaceutical settings
    • At least 2 years in Medical Affairs or Clinical Development roles with a track record of success in oncology
  • Knowledge:
    • Deep knowledge of treatment paradigms, clinical guidelines, and diagnostic workflows in breast cancer
    • Expertise in clinical trial design, regulatory/compliance frameworks, and biostatistics

Responsibilities

  • Clinical Strategy: Partner with the Medical Director, Oncology to develop and execute clinical strategies supporting Natera’s molecular diagnostic tools for breast cancer, including minimal residual disease (MRD) and ctDNA-based monitoring.
  • Clinical Study Leadership: Lead the design and implementation of clinical studies and treatment protocols that integrate Natera’s technology into standard breast oncology care.
  • Site Recruitment & Management: Recruit and engage leading principal investigators (PIs) and clinical sites to participate in company-sponsored studies; manage study timelines and budgets in collaboration with Clinical Trial Operations.
  • Product Development Input: Advise on product development for the breast cancer portfolio, identifying clinical unmet needs, new product opportunities, key product features, intended use, test report content, and minimum validation requirements.
  • Post-Launch Support: Provide post-launch medical affairs support, including interpretation of test results, clinical consultation for healthcare providers, and guidance on patient counseling (pre- and post-test).
  • Medical Education: Lead medical education initiatives, including external training, launch planning, and the creation of scientific and clinical materials.
  • Key Opinion Leader (KOL) Engagement: Identify and recruit Key Opinion Leaders (KOLs) in breast oncology to serve on advisory boards and contribute to strategic planning.
  • Publication Support: Support the publication strategy by collaborating with Scientific Communications on manuscripts, abstracts, and conference presentations.
  • Regulatory Support: Contribute to regulatory strategy by providing medical input into submissions related to breast cancer diagnostic products.
  • External Representation: Represent Natera’s medical voice externally through public relations, industry panels, advisory boards, and medical conferences.
  • Compliance: Ensure compliance with Natera’s HIPAA/PHI privacy, compliance, and data security training within 30 days of hire, and maintain ongoing compliance.

Application Instructions

  • Not Specified

Company Information

  • Not Specified

Skills

Clinical trial design
Regulatory frameworks
Biostatistics
Breast oncology treatment paradigms
Clinical guidelines
Diagnostic workflows
Leadership
Stakeholder engagement

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI